Women who carry harmful changes in the BRCA1 or BRCA2 genes face a high chance of developing tubo‑ovarian cancer, the most deadly female reproductive system cancer. Because no good screening test exists, doctors usually recommend removing both tubes and ovaries early to cut the risk. This surgery st
Breast cancer treatment has seen a significant shift with the introduction of PARP inhibitors. This change has brought mainstreaming cancer genetics into the spotlight. This approach uses genetic information to predict how well a patient will respond to treatment. As a result, the criteria for BRCA
Ovarian cancer is a serious health issue. It is the fifth most common cancer in women. It is also the leading cause of death from gynecological cancers. The disease often goes undetected until it has spread. This makes it tough to treat. Doctors have been looking into ways to improve outcomes f
Scientists in Tehran have been digging into the mysteries of breast cancer. They've been looking at something called the BRCA1 gene and a protein named CA15-3. By collecting samples from patients with breast cancer, they found that a significant portion, about a quarter, had an active BRCA1 gene. Th
Ever wondered about the link between genes and pancreatic cancer in women? Let's dive into the scene with BRCA1 and BRCA2 mutations. These genetic changes can affect the lifetime risk of pancreatic cancer, but we're still trying to fully grasp how much. A global study watched over female BRCA1 and B
